Global Porcine Epidemic Diarrhea Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Porcine Epidemic Diarrhea Vaccines market size was valued at USD 158.5 million in 2023 and is forecast to a readjusted size of USD 247.9 million by 2030 with a CAGR of 6.6% during review period.
Porcine epidemic diarrhea virus (PEDV) is the causative agent of porcine epidemic diarrhea (PED), an acute and highly contagious enteric viral disease.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
The Global Info Research report includes an overview of the development of the Porcine Epidemic Diarrhea Vaccines industry chain, the market status of Piglets (Live Vaccines, Killed Vaccines), Adults Pigs (Live Vaccines, Killed Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Porcine Epidemic Diarrhea Vaccines.
Regionally, the report analyzes the Porcine Epidemic Diarrhea Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Porcine Epidemic Diarrhea Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Porcine Epidemic Diarrhea Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Porcine Epidemic Diarrhea Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Units), revenue generated, and market share of different by Type (e.g., Live Vaccines, Killed Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Porcine Epidemic Diarrhea Vaccines market.
Regional Analysis: The report involves examining the Porcine Epidemic Diarrhea Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Porcine Epidemic Diarrhea Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Porcine Epidemic Diarrhea Vaccines:
Company Analysis: Report covers individual Porcine Epidemic Diarrhea Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Porcine Epidemic Diarrhea Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Piglets, Adults Pigs).
Technology Analysis: Report covers specific technologies relevant to Porcine Epidemic Diarrhea Vaccines. It assesses the current state, advancements, and potential future developments in Porcine Epidemic Diarrhea Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Porcine Epidemic Diarrhea Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Porcine Epidemic Diarrhea Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Porcine Epidemic Diarrhea Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Porcine Epidemic Diarrhea Vaccines, with price, sales, revenue and global market share of Porcine Epidemic Diarrhea Vaccines from 2019 to 2024.
Chapter 3, the Porcine Epidemic Diarrhea Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Porcine Epidemic Diarrhea Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Porcine Epidemic Diarrhea Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Porcine Epidemic Diarrhea Vaccines.
Chapter 14 and 15, to describe Porcine Epidemic Diarrhea Vaccines sales channel, distributors, customers, research findings and conclusion.
Porcine epidemic diarrhea virus (PEDV) is the causative agent of porcine epidemic diarrhea (PED), an acute and highly contagious enteric viral disease.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
The Global Info Research report includes an overview of the development of the Porcine Epidemic Diarrhea Vaccines industry chain, the market status of Piglets (Live Vaccines, Killed Vaccines), Adults Pigs (Live Vaccines, Killed Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Porcine Epidemic Diarrhea Vaccines.
Regionally, the report analyzes the Porcine Epidemic Diarrhea Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Porcine Epidemic Diarrhea Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Porcine Epidemic Diarrhea Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Porcine Epidemic Diarrhea Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Units), revenue generated, and market share of different by Type (e.g., Live Vaccines, Killed Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Porcine Epidemic Diarrhea Vaccines market.
Regional Analysis: The report involves examining the Porcine Epidemic Diarrhea Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Porcine Epidemic Diarrhea Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Porcine Epidemic Diarrhea Vaccines:
Company Analysis: Report covers individual Porcine Epidemic Diarrhea Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Porcine Epidemic Diarrhea Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Piglets, Adults Pigs).
Technology Analysis: Report covers specific technologies relevant to Porcine Epidemic Diarrhea Vaccines. It assesses the current state, advancements, and potential future developments in Porcine Epidemic Diarrhea Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Porcine Epidemic Diarrhea Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Porcine Epidemic Diarrhea Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Live Vaccines
- Killed Vaccines
- Piglets
- Adults Pigs
- CAVAC
- Green Cross Veterinary Products
- Harrisvaccines
- Komipharm
- Nisseiken
- Qilu Animal Health
- Zoetis
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Porcine Epidemic Diarrhea Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Porcine Epidemic Diarrhea Vaccines, with price, sales, revenue and global market share of Porcine Epidemic Diarrhea Vaccines from 2019 to 2024.
Chapter 3, the Porcine Epidemic Diarrhea Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Porcine Epidemic Diarrhea Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Porcine Epidemic Diarrhea Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Porcine Epidemic Diarrhea Vaccines.
Chapter 14 and 15, to describe Porcine Epidemic Diarrhea Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Porcine Epidemic Diarrhea Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Live Vaccines
1.3.3 Killed Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Piglets
1.4.3 Adults Pigs
1.5 Global Porcine Epidemic Diarrhea Vaccines Market Size & Forecast
1.5.1 Global Porcine Epidemic Diarrhea Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Porcine Epidemic Diarrhea Vaccines Sales Quantity (2019-2030)
1.5.3 Global Porcine Epidemic Diarrhea Vaccines Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 CAVAC
2.1.1 CAVAC Details
2.1.2 CAVAC Major Business
2.1.3 CAVAC Porcine Epidemic Diarrhea Vaccines Product and Services
2.1.4 CAVAC Porcine Epidemic Diarrhea Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 CAVAC Recent Developments/Updates
2.2 Green Cross Veterinary Products
2.2.1 Green Cross Veterinary Products Details
2.2.2 Green Cross Veterinary Products Major Business
2.2.3 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Product and Services
2.2.4 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Green Cross Veterinary Products Recent Developments/Updates
2.3 Harrisvaccines
2.3.1 Harrisvaccines Details
2.3.2 Harrisvaccines Major Business
2.3.3 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Product and Services
2.3.4 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Harrisvaccines Recent Developments/Updates
2.4 Komipharm
2.4.1 Komipharm Details
2.4.2 Komipharm Major Business
2.4.3 Komipharm Porcine Epidemic Diarrhea Vaccines Product and Services
2.4.4 Komipharm Porcine Epidemic Diarrhea Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Komipharm Recent Developments/Updates
2.5 Nisseiken
2.5.1 Nisseiken Details
2.5.2 Nisseiken Major Business
2.5.3 Nisseiken Porcine Epidemic Diarrhea Vaccines Product and Services
2.5.4 Nisseiken Porcine Epidemic Diarrhea Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Nisseiken Recent Developments/Updates
2.6 Qilu Animal Health
2.6.1 Qilu Animal Health Details
2.6.2 Qilu Animal Health Major Business
2.6.3 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Product and Services
2.6.4 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Qilu Animal Health Recent Developments/Updates
2.7 Zoetis
2.7.1 Zoetis Details
2.7.2 Zoetis Major Business
2.7.3 Zoetis Porcine Epidemic Diarrhea Vaccines Product and Services
2.7.4 Zoetis Porcine Epidemic Diarrhea Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Zoetis Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PORCINE EPIDEMIC DIARRHEA VACCINES BY MANUFACTURER
3.1 Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Porcine Epidemic Diarrhea Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Porcine Epidemic Diarrhea Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Porcine Epidemic Diarrhea Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Porcine Epidemic Diarrhea Vaccines Manufacturer Market Share in 2023
3.5 Porcine Epidemic Diarrhea Vaccines Market: Overall Company Footprint Analysis
3.5.1 Porcine Epidemic Diarrhea Vaccines Market: Region Footprint
3.5.2 Porcine Epidemic Diarrhea Vaccines Market: Company Product Type Footprint
3.5.3 Porcine Epidemic Diarrhea Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Porcine Epidemic Diarrhea Vaccines Market Size by Region
4.1.1 Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Porcine Epidemic Diarrhea Vaccines Average Price by Region (2019-2030)
4.2 North America Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030)
4.3 Europe Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030)
4.5 South America Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Type (2019-2030)
5.3 Global Porcine Epidemic Diarrhea Vaccines Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2030)
6.2 Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Application (2019-2030)
6.3 Global Porcine Epidemic Diarrhea Vaccines Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2030)
7.3 North America Porcine Epidemic Diarrhea Vaccines Market Size by Country
7.3.1 North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe Porcine Epidemic Diarrhea Vaccines Market Size by Country
8.3.1 Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market Size by Region
9.3.1 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2030)
10.3 South America Porcine Epidemic Diarrhea Vaccines Market Size by Country
10.3.1 South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Market Size by Country
11.3.1 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Porcine Epidemic Diarrhea Vaccines Market Drivers
12.2 Porcine Epidemic Diarrhea Vaccines Market Restraints
12.3 Porcine Epidemic Diarrhea Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Porcine Epidemic Diarrhea Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Porcine Epidemic Diarrhea Vaccines
13.3 Porcine Epidemic Diarrhea Vaccines Production Process
13.4 Porcine Epidemic Diarrhea Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Porcine Epidemic Diarrhea Vaccines Typical Distributors
14.3 Porcine Epidemic Diarrhea Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Porcine Epidemic Diarrhea Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Live Vaccines
1.3.3 Killed Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Piglets
1.4.3 Adults Pigs
1.5 Global Porcine Epidemic Diarrhea Vaccines Market Size & Forecast
1.5.1 Global Porcine Epidemic Diarrhea Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Porcine Epidemic Diarrhea Vaccines Sales Quantity (2019-2030)
1.5.3 Global Porcine Epidemic Diarrhea Vaccines Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 CAVAC
2.1.1 CAVAC Details
2.1.2 CAVAC Major Business
2.1.3 CAVAC Porcine Epidemic Diarrhea Vaccines Product and Services
2.1.4 CAVAC Porcine Epidemic Diarrhea Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 CAVAC Recent Developments/Updates
2.2 Green Cross Veterinary Products
2.2.1 Green Cross Veterinary Products Details
2.2.2 Green Cross Veterinary Products Major Business
2.2.3 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Product and Services
2.2.4 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Green Cross Veterinary Products Recent Developments/Updates
2.3 Harrisvaccines
2.3.1 Harrisvaccines Details
2.3.2 Harrisvaccines Major Business
2.3.3 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Product and Services
2.3.4 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Harrisvaccines Recent Developments/Updates
2.4 Komipharm
2.4.1 Komipharm Details
2.4.2 Komipharm Major Business
2.4.3 Komipharm Porcine Epidemic Diarrhea Vaccines Product and Services
2.4.4 Komipharm Porcine Epidemic Diarrhea Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Komipharm Recent Developments/Updates
2.5 Nisseiken
2.5.1 Nisseiken Details
2.5.2 Nisseiken Major Business
2.5.3 Nisseiken Porcine Epidemic Diarrhea Vaccines Product and Services
2.5.4 Nisseiken Porcine Epidemic Diarrhea Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Nisseiken Recent Developments/Updates
2.6 Qilu Animal Health
2.6.1 Qilu Animal Health Details
2.6.2 Qilu Animal Health Major Business
2.6.3 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Product and Services
2.6.4 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Qilu Animal Health Recent Developments/Updates
2.7 Zoetis
2.7.1 Zoetis Details
2.7.2 Zoetis Major Business
2.7.3 Zoetis Porcine Epidemic Diarrhea Vaccines Product and Services
2.7.4 Zoetis Porcine Epidemic Diarrhea Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Zoetis Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PORCINE EPIDEMIC DIARRHEA VACCINES BY MANUFACTURER
3.1 Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Porcine Epidemic Diarrhea Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Porcine Epidemic Diarrhea Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Porcine Epidemic Diarrhea Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Porcine Epidemic Diarrhea Vaccines Manufacturer Market Share in 2023
3.5 Porcine Epidemic Diarrhea Vaccines Market: Overall Company Footprint Analysis
3.5.1 Porcine Epidemic Diarrhea Vaccines Market: Region Footprint
3.5.2 Porcine Epidemic Diarrhea Vaccines Market: Company Product Type Footprint
3.5.3 Porcine Epidemic Diarrhea Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Porcine Epidemic Diarrhea Vaccines Market Size by Region
4.1.1 Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Porcine Epidemic Diarrhea Vaccines Average Price by Region (2019-2030)
4.2 North America Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030)
4.3 Europe Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030)
4.5 South America Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Type (2019-2030)
5.3 Global Porcine Epidemic Diarrhea Vaccines Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2030)
6.2 Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Application (2019-2030)
6.3 Global Porcine Epidemic Diarrhea Vaccines Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2030)
7.3 North America Porcine Epidemic Diarrhea Vaccines Market Size by Country
7.3.1 North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe Porcine Epidemic Diarrhea Vaccines Market Size by Country
8.3.1 Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market Size by Region
9.3.1 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2030)
10.3 South America Porcine Epidemic Diarrhea Vaccines Market Size by Country
10.3.1 South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Market Size by Country
11.3.1 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Porcine Epidemic Diarrhea Vaccines Market Drivers
12.2 Porcine Epidemic Diarrhea Vaccines Market Restraints
12.3 Porcine Epidemic Diarrhea Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Porcine Epidemic Diarrhea Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Porcine Epidemic Diarrhea Vaccines
13.3 Porcine Epidemic Diarrhea Vaccines Production Process
13.4 Porcine Epidemic Diarrhea Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Porcine Epidemic Diarrhea Vaccines Typical Distributors
14.3 Porcine Epidemic Diarrhea Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. CAVAC Basic Information, Manufacturing Base and Competitors
Table 4. CAVAC Major Business
Table 5. CAVAC Porcine Epidemic Diarrhea Vaccines Product and Services
Table 6. CAVAC Porcine Epidemic Diarrhea Vaccines Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. CAVAC Recent Developments/Updates
Table 8. Green Cross Veterinary Products Basic Information, Manufacturing Base and Competitors
Table 9. Green Cross Veterinary Products Major Business
Table 10. Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Product and Services
Table 11. Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Green Cross Veterinary Products Recent Developments/Updates
Table 13. Harrisvaccines Basic Information, Manufacturing Base and Competitors
Table 14. Harrisvaccines Major Business
Table 15. Harrisvaccines Porcine Epidemic Diarrhea Vaccines Product and Services
Table 16. Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Harrisvaccines Recent Developments/Updates
Table 18. Komipharm Basic Information, Manufacturing Base and Competitors
Table 19. Komipharm Major Business
Table 20. Komipharm Porcine Epidemic Diarrhea Vaccines Product and Services
Table 21. Komipharm Porcine Epidemic Diarrhea Vaccines Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Komipharm Recent Developments/Updates
Table 23. Nisseiken Basic Information, Manufacturing Base and Competitors
Table 24. Nisseiken Major Business
Table 25. Nisseiken Porcine Epidemic Diarrhea Vaccines Product and Services
Table 26. Nisseiken Porcine Epidemic Diarrhea Vaccines Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Nisseiken Recent Developments/Updates
Table 28. Qilu Animal Health Basic Information, Manufacturing Base and Competitors
Table 29. Qilu Animal Health Major Business
Table 30. Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Product and Services
Table 31. Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Qilu Animal Health Recent Developments/Updates
Table 33. Zoetis Basic Information, Manufacturing Base and Competitors
Table 34. Zoetis Major Business
Table 35. Zoetis Porcine Epidemic Diarrhea Vaccines Product and Services
Table 36. Zoetis Porcine Epidemic Diarrhea Vaccines Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Zoetis Recent Developments/Updates
Table 38. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Manufacturer (2019-2024) & (M Units)
Table 39. Global Porcine Epidemic Diarrhea Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 40. Global Porcine Epidemic Diarrhea Vaccines Average Price by Manufacturer (2019-2024) & (USD/K Unit)
Table 41. Market Position of Manufacturers in Porcine Epidemic Diarrhea Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 42. Head Office and Porcine Epidemic Diarrhea Vaccines Production Site of Key Manufacturer
Table 43. Porcine Epidemic Diarrhea Vaccines Market: Company Product Type Footprint
Table 44. Porcine Epidemic Diarrhea Vaccines Market: Company Product Application Footprint
Table 45. Porcine Epidemic Diarrhea Vaccines New Market Entrants and Barriers to Market Entry
Table 46. Porcine Epidemic Diarrhea Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Region (2019-2024) & (M Units)
Table 48. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Region (2025-2030) & (M Units)
Table 49. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 50. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 51. Global Porcine Epidemic Diarrhea Vaccines Average Price by Region (2019-2024) & (USD/K Unit)
Table 52. Global Porcine Epidemic Diarrhea Vaccines Average Price by Region (2025-2030) & (USD/K Unit)
Table 53. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2024) & (M Units)
Table 54. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2025-2030) & (M Units)
Table 55. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Global Porcine Epidemic Diarrhea Vaccines Average Price by Type (2019-2024) & (USD/K Unit)
Table 58. Global Porcine Epidemic Diarrhea Vaccines Average Price by Type (2025-2030) & (USD/K Unit)
Table 59. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2024) & (M Units)
Table 60. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2025-2030) & (M Units)
Table 61. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 62. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 63. Global Porcine Epidemic Diarrhea Vaccines Average Price by Application (2019-2024) & (USD/K Unit)
Table 64. Global Porcine Epidemic Diarrhea Vaccines Average Price by Application (2025-2030) & (USD/K Unit)
Table 65. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2024) & (M Units)
Table 66. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2025-2030) & (M Units)
Table 67. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2024) & (M Units)
Table 68. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2025-2030) & (M Units)
Table 69. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2019-2024) & (M Units)
Table 70. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2025-2030) & (M Units)
Table 71. North America Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 72. North America Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2024) & (M Units)
Table 74. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2025-2030) & (M Units)
Table 75. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2024) & (M Units)
Table 76. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2025-2030) & (M Units)
Table 77. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2019-2024) & (M Units)
Table 78. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2025-2030) & (M Units)
Table 79. Europe Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2024) & (M Units)
Table 82. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2025-2030) & (M Units)
Table 83. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2024) & (M Units)
Table 84. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2025-2030) & (M Units)
Table 85. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Region (2019-2024) & (M Units)
Table 86. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Region (2025-2030) & (M Units)
Table 87. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 88. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 89. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2024) & (M Units)
Table 90. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2025-2030) & (M Units)
Table 91. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2024) & (M Units)
Table 92. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2025-2030) & (M Units)
Table 93. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2019-2024) & (M Units)
Table 94. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2025-2030) & (M Units)
Table 95. South America Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 96. South America Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2024) & (M Units)
Table 98. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2025-2030) & (M Units)
Table 99. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2024) & (M Units)
Table 100. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2025-2030) & (M Units)
Table 101. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Region (2019-2024) & (M Units)
Table 102. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Region (2025-2030) & (M Units)
Table 103. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 105. Porcine Epidemic Diarrhea Vaccines Raw Material
Table 106. Key Manufacturers of Porcine Epidemic Diarrhea Vaccines Raw Materials
Table 107. Porcine Epidemic Diarrhea Vaccines Typical Distributors
Table 108. Porcine Epidemic Diarrhea Vaccines Typical Customers
Table 1. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. CAVAC Basic Information, Manufacturing Base and Competitors
Table 4. CAVAC Major Business
Table 5. CAVAC Porcine Epidemic Diarrhea Vaccines Product and Services
Table 6. CAVAC Porcine Epidemic Diarrhea Vaccines Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. CAVAC Recent Developments/Updates
Table 8. Green Cross Veterinary Products Basic Information, Manufacturing Base and Competitors
Table 9. Green Cross Veterinary Products Major Business
Table 10. Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Product and Services
Table 11. Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Green Cross Veterinary Products Recent Developments/Updates
Table 13. Harrisvaccines Basic Information, Manufacturing Base and Competitors
Table 14. Harrisvaccines Major Business
Table 15. Harrisvaccines Porcine Epidemic Diarrhea Vaccines Product and Services
Table 16. Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Harrisvaccines Recent Developments/Updates
Table 18. Komipharm Basic Information, Manufacturing Base and Competitors
Table 19. Komipharm Major Business
Table 20. Komipharm Porcine Epidemic Diarrhea Vaccines Product and Services
Table 21. Komipharm Porcine Epidemic Diarrhea Vaccines Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Komipharm Recent Developments/Updates
Table 23. Nisseiken Basic Information, Manufacturing Base and Competitors
Table 24. Nisseiken Major Business
Table 25. Nisseiken Porcine Epidemic Diarrhea Vaccines Product and Services
Table 26. Nisseiken Porcine Epidemic Diarrhea Vaccines Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Nisseiken Recent Developments/Updates
Table 28. Qilu Animal Health Basic Information, Manufacturing Base and Competitors
Table 29. Qilu Animal Health Major Business
Table 30. Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Product and Services
Table 31. Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Qilu Animal Health Recent Developments/Updates
Table 33. Zoetis Basic Information, Manufacturing Base and Competitors
Table 34. Zoetis Major Business
Table 35. Zoetis Porcine Epidemic Diarrhea Vaccines Product and Services
Table 36. Zoetis Porcine Epidemic Diarrhea Vaccines Sales Quantity (M Units), Average Price (USD/K Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Zoetis Recent Developments/Updates
Table 38. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Manufacturer (2019-2024) & (M Units)
Table 39. Global Porcine Epidemic Diarrhea Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 40. Global Porcine Epidemic Diarrhea Vaccines Average Price by Manufacturer (2019-2024) & (USD/K Unit)
Table 41. Market Position of Manufacturers in Porcine Epidemic Diarrhea Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 42. Head Office and Porcine Epidemic Diarrhea Vaccines Production Site of Key Manufacturer
Table 43. Porcine Epidemic Diarrhea Vaccines Market: Company Product Type Footprint
Table 44. Porcine Epidemic Diarrhea Vaccines Market: Company Product Application Footprint
Table 45. Porcine Epidemic Diarrhea Vaccines New Market Entrants and Barriers to Market Entry
Table 46. Porcine Epidemic Diarrhea Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Region (2019-2024) & (M Units)
Table 48. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Region (2025-2030) & (M Units)
Table 49. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 50. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 51. Global Porcine Epidemic Diarrhea Vaccines Average Price by Region (2019-2024) & (USD/K Unit)
Table 52. Global Porcine Epidemic Diarrhea Vaccines Average Price by Region (2025-2030) & (USD/K Unit)
Table 53. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2024) & (M Units)
Table 54. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2025-2030) & (M Units)
Table 55. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Global Porcine Epidemic Diarrhea Vaccines Average Price by Type (2019-2024) & (USD/K Unit)
Table 58. Global Porcine Epidemic Diarrhea Vaccines Average Price by Type (2025-2030) & (USD/K Unit)
Table 59. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2024) & (M Units)
Table 60. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2025-2030) & (M Units)
Table 61. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 62. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 63. Global Porcine Epidemic Diarrhea Vaccines Average Price by Application (2019-2024) & (USD/K Unit)
Table 64. Global Porcine Epidemic Diarrhea Vaccines Average Price by Application (2025-2030) & (USD/K Unit)
Table 65. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2024) & (M Units)
Table 66. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2025-2030) & (M Units)
Table 67. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2024) & (M Units)
Table 68. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2025-2030) & (M Units)
Table 69. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2019-2024) & (M Units)
Table 70. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2025-2030) & (M Units)
Table 71. North America Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 72. North America Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2024) & (M Units)
Table 74. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2025-2030) & (M Units)
Table 75. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2024) & (M Units)
Table 76. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2025-2030) & (M Units)
Table 77. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2019-2024) & (M Units)
Table 78. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2025-2030) & (M Units)
Table 79. Europe Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2024) & (M Units)
Table 82. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2025-2030) & (M Units)
Table 83. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2024) & (M Units)
Table 84. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2025-2030) & (M Units)
Table 85. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Region (2019-2024) & (M Units)
Table 86. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity by Region (2025-2030) & (M Units)
Table 87. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 88. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 89. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2024) & (M Units)
Table 90. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2025-2030) & (M Units)
Table 91. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2024) & (M Units)
Table 92. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2025-2030) & (M Units)
Table 93. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2019-2024) & (M Units)
Table 94. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity by Country (2025-2030) & (M Units)
Table 95. South America Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 96. South America Porcine Epidemic Diarrhea Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2019-2024) & (M Units)
Table 98. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Type (2025-2030) & (M Units)
Table 99. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2019-2024) & (M Units)
Table 100. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Application (2025-2030) & (M Units)
Table 101. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Region (2019-2024) & (M Units)
Table 102. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity by Region (2025-2030) & (M Units)
Table 103. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 105. Porcine Epidemic Diarrhea Vaccines Raw Material
Table 106. Key Manufacturers of Porcine Epidemic Diarrhea Vaccines Raw Materials
Table 107. Porcine Epidemic Diarrhea Vaccines Typical Distributors
Table 108. Porcine Epidemic Diarrhea Vaccines Typical Customers
LIST OF FIGURES
Figure 1. Porcine Epidemic Diarrhea Vaccines Picture
Figure 2. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Live Vaccines Examples
Figure 5. Killed Vaccines Examples
Figure 6. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Application in 2023
Figure 8. Piglets Examples
Figure 9. Adults Pigs Examples
Figure 10. Global Porcine Epidemic Diarrhea Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Porcine Epidemic Diarrhea Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity (2019-2030) & (M Units)
Figure 13. Global Porcine Epidemic Diarrhea Vaccines Average Price (2019-2030) & (USD/K Unit)
Figure 14. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Porcine Epidemic Diarrhea Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Porcine Epidemic Diarrhea Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Porcine Epidemic Diarrhea Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Porcine Epidemic Diarrhea Vaccines Average Price by Type (2019-2030) & (USD/K Unit)
Figure 29. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Porcine Epidemic Diarrhea Vaccines Average Price by Application (2019-2030) & (USD/K Unit)
Figure 32. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 52. China Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Porcine Epidemic Diarrhea Vaccines Market Drivers
Figure 73. Porcine Epidemic Diarrhea Vaccines Market Restraints
Figure 74. Porcine Epidemic Diarrhea Vaccines Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Porcine Epidemic Diarrhea Vaccines in 2023
Figure 77. Manufacturing Process Analysis of Porcine Epidemic Diarrhea Vaccines
Figure 78. Porcine Epidemic Diarrhea Vaccines Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Porcine Epidemic Diarrhea Vaccines Picture
Figure 2. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Live Vaccines Examples
Figure 5. Killed Vaccines Examples
Figure 6. Global Porcine Epidemic Diarrhea Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Application in 2023
Figure 8. Piglets Examples
Figure 9. Adults Pigs Examples
Figure 10. Global Porcine Epidemic Diarrhea Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Porcine Epidemic Diarrhea Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity (2019-2030) & (M Units)
Figure 13. Global Porcine Epidemic Diarrhea Vaccines Average Price (2019-2030) & (USD/K Unit)
Figure 14. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Porcine Epidemic Diarrhea Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Porcine Epidemic Diarrhea Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Porcine Epidemic Diarrhea Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Porcine Epidemic Diarrhea Vaccines Average Price by Type (2019-2030) & (USD/K Unit)
Figure 29. Global Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Porcine Epidemic Diarrhea Vaccines Average Price by Application (2019-2030) & (USD/K Unit)
Figure 32. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 52. China Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Porcine Epidemic Diarrhea Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Porcine Epidemic Diarrhea Vaccines Market Drivers
Figure 73. Porcine Epidemic Diarrhea Vaccines Market Restraints
Figure 74. Porcine Epidemic Diarrhea Vaccines Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Porcine Epidemic Diarrhea Vaccines in 2023
Figure 77. Manufacturing Process Analysis of Porcine Epidemic Diarrhea Vaccines
Figure 78. Porcine Epidemic Diarrhea Vaccines Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
